Jamie Lurie, MD
Allergy & Immunology · New Orleans, LANPI 1124203708
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.3% of the total across 76 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Sanofi at 24.3% of the total. That places this record below the midpoint for allergy & immunology clinicians in LA, where the typical reported total is $3,029.
Across 76 payments — averaging $24.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$457
- GSK$295
- AstraZeneca$271
- Regeneron Healthcare Solutions, Inc.$128
- Organon$127
- Takeda Pharmaceuticals U.S.A., Inc.$93
- plus $511 from 16 others
What the payments were for
- Food & beverage$1,79395%
- Education$895%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 14 | $457 |
| GSK | 20 | $295 |
| AstraZeneca | 8 | $271 |
| Regeneron Healthcare Solutions, Inc. | 5 | $128 |
| Organon | 1 | $127 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $93 |
| Amgen | 3 | $67 |
| Novartis | 3 | $59 |
| Merck | 4 | $55 |
| Sanofi-aventis U.S. LLC | 1 | $55 |
| Genentech USA, Inc. | 2 | $39 |
| Pinnacle Biologics, Inc | 1 | $32 |
| Ultragenyx Pharmaceutical Inc. | 1 | $30 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $28 |
| Abbott | 1 | $22 |
| Mylan Specialty L.p. | 1 | $20 |
| Phadia US Inc. | 1 | $20 |
| Boehringer Ingelheim | 1 | $20 |
| Hikma Pharmaceuticals USA | 1 | $20 |
| Shire North American Group Inc | 1 | $17 |
| Pfizer | 1 | $15 |
| Novo Nordisk | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,882 in reported general payments places this provider in the 40th percentile of 62 allergy & immunology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fasenra PenBenralizumab | 12 | $66,014 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 26 | $15,925 |
| Spiriva RespimatTiotropium Bromide | 14 | $14,685 |
| Advair HfaFluticasone Propion/Salmeterol | 25 | $11,680 |
| DuleraMometasone/Formoterol | 32 | $10,181 |
| SymbicortBudesonide/Formoterol Fumarate | 34 | $9,003 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $6,972 |
| Epinephrine | 15 | $2,395 |
| Fluticasone Propionate | 91 | $1,638 |
| Montelukast Sodium | 164 | $1,330 |
| Mometasone Furoate | 11 | $935 |
| Azelastine Hcl | 27 | $709 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 20 | $556 |
| Levocetirizine Dihydrochloride | 78 | $541 |
| Famotidine | 45 | $530 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $295 | $22,89737 claims |
| Boehringer IngelheimSpiriva Respimat | $20 | $14,68514 claims |
| MerckDulera | $55 | $10,18132 claims |
| AstraZenecaSymbicort | $271 | $9,00334 claims |
| Hikma Pharmaceuticals USAEpinephrine | $20 | $2,39515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 62 allergy & immunology providers in Louisiana.
Other allergy & immunology in New Orleans
- Reena MehtaNew Orleans$159K
- Kenneth ParisNew Orleans$150K
- Cheryl WilliamsNew Orleans$12K
- Luke WallNew Orleans$7K
- Stephen DerbesNew Orleans$2K
- Michelle Korah-SedgwickNew Orleans$2K
- William DavisNew Orleans$2K
- Elizabeth WisnerNew Orleans$2K
- Dexter MatranaNew Orleans$1K
- Meaghan McMahonNew Orleans$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.